Skip to content

Clinical trials

Phase 4 Myocardial Infarction trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 4 Country / region: Netherlands Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20102
20113
20141
20151
20171
20202
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Antonius Hospital3
R&D Cardiologie2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Amsterdam UMC, location VUmc1
AstraZeneca1
Foundation of Cardiovascular Research and Education Enschede1
Heartcenter, University Medical Center St. Radboud1
Maasstad Hospital1
Medical University of Warsaw1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction16
Cardiovascular Diseases4
Heart Diseases4
ST Elevation Myocardial Infarction4
Stroke4
Thrombosis4
Acute Coronary Syndrome3
Coronary Artery Disease3
Embolism and Thrombosis3
Hemorrhage3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.